Geneos Wealth Management’s iShares Core 60/40 Balanced Allocation ETF AOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $305K | Sell |
4,395
-15
| -0.3% | -$1.02K | 0.01% | 864 |
|
|
2026
Q1 | $284K | Buy |
4,410
+2,310
| +110% | +$152K | 0.01% | 853 |
|
|
2025
Q4 | $137K | Sell |
2,100
-444
| -17% | -$28.8K | ﹤0.01% | 1058 |
|
|
2025
Q3 | $164K | Buy |
2,544
+404
| +19% | +$25.3K | ﹤0.01% | 966 |
|
|
2025
Q2 | $132K | Sell |
2,140
-1,604
| -43% | -$93.7K | ﹤0.01% | 1142 |
|
|
2025
Q1 | $216K | Buy |
3,744
+1,862
| +99% | +$108K | ﹤0.01% | 1202 |
|
|
2024
Q4 | $108K | Buy |
1,882
+189
| +11% | +$11.1K | ﹤0.01% | 1045 |
|
|
2024
Q3 | $100K | Hold |
1,693
| – | – | ﹤0.01% | 968 |
|
|
2024
Q2 | $95.3K | Hold |
1,693
| – | – | ﹤0.01% | 878 |
|
|
2024
Q1 | $94.2K | Buy |
1,693
+130
| +8% | +$7.01K | ﹤0.01% | 866 |
|
|
2023
Q4 | $83.1K | Buy |
1,563
+204
| +15% | +$10.3K | ﹤0.01% | 890 |
|
|
2023
Q3 | $67.1K | Buy |
1,359
+134
| +11% | +$6.82K | ﹤0.01% | 987 |
|
|
2023
Q2 | $63K | Sell |
1,225
-703
| -36% | -$35.4K | ﹤0.01% | 1010 |
|
|
2023
Q1 | $96.5K | Buy |
1,928
+1,209
| +168% | +$59.5K | 0.01% | 854 |
|
|
2022
Q4 | $33.9K | Hold |
719
| – | – | ﹤0.01% | 1183 |
|
|
2022
Q3 | $32K | Sell |
719
-10,723
| -94% | -$519K | ﹤0.01% | 1179 |
|
|
2022
Q2 | $551K | Buy |
11,442
+581
| +5% | +$29.2K | 0.03% | 469 |
|
|
2022
Q1 | $586K | Sell |
10,861
-1,803
| -14% | -$98.2K | 0.03% | 494 |
|
|
2021
Q4 | $722K | Buy |
12,664
+935
| +8% | +$53K | 0.03% | 481 |
|
|
2021
Q3 | $654K | Sell |
11,729
-106
| -0.9% | -$5.98K | 0.03% | 502 |
|
|
2021
Q2 | $663K | Sell |
11,835
-1,692
| -13% | -$93.5K | 0.03% | 482 |
|
|
2021
Q1 | $742K | Sell |
13,527
-613
| -4% | -$32.6K | 0.02% | 521 |
|
|
2020
Q4 | $648K | Buy |
14,140
+3,590
| +34% | +$181K | 0.03% | 465 |
|
|
2020
Q3 | $505K | Sell |
10,550
-480
| -4% | -$23.1K | 0.03% | 427 |
|
|
2020
Q2 | $505K | Buy |
11,030
+351
| +3% | +$15.6K | 0.03% | 411 |
|
|
2020
Q1 | $438K | Buy |
10,679
+520
| +5% | +$23.9K | 0.03% | 399 |
|
|
2019
Q4 | $486K | Buy |
10,159
+5,805
| +133% | +$272K | 0.03% | 444 |
|
|
2019
Q3 | $200K | Sell |
4,354
-15
| -0.3% | -$685 | 0.01% | 661 |
|
|
2019
Q2 | $201K | Buy |
4,369
+22
| +0.5% | +$991 | 0.01% | 662 |
|
|
2019
Q1 | $194K | Buy |
4,347
+1,285
| +42% | +$55.8K | 0.01% | 648 |
|
|
2018
Q4 | $125K | Sell |
3,062
-649
| -17% | -$27.8K | 0.01% | 759 |
|
|
2018
Q3 | $167K | Buy |
3,711
+681
| +22% | +$30.5K | 0.01% | 707 |
|
|
2018
Q2 | $134K | Buy |
3,030
+277
| +10% | +$12.4K | 0.01% | 692 |
|
|
2018
Q1 | $122K | Sell |
2,753
-575
| -17% | -$26K | 0.01% | 685 |
|
|
2017
Q4 | $149K | Sell |
3,328
-135
| -4% | -$6.13K | 0.01% | 620 |
|
|
2017
Q3 | $155K | Sell |
3,463
-41
| -1% | -$1.81K | 0.02% | 585 |
|
|
2017
Q2 | $152K | Buy |
3,504
+162
| +5% | +$6.99K | 0.02% | 566 |
|
|
2017
Q1 | $141K | Sell |
3,342
-1,639
| -33% | -$68.3K | 0.01% | 565 |
|
|
2016
Q4 | $202K | Buy |
4,981
+179
| +4% | +$7.24K | 0.03% | 457 |
|
|
2016
Q3 | $197K | Buy |
4,802
+66
| +1% | +$2.69K | 0.03% | 448 |
|
|
2016
Q2 | $190K | Buy |
4,736
+915
| +24% | +$36.2K | 0.03% | 457 |
|
|
2016
Q1 | $150K | Buy |
+3,821
| New | +$145K | 0.02% | 491 |
|
Other funds holding AOR
WAM
MFIM
AL
CWA
Geneos Wealth Management's AOR Position: Q2 2026 in Review
Geneos Wealth Management reduced its iShares Core 60/40 Balanced Allocation ETF (AOR) stake by 0.34% in Q2 2026, selling an estimated $1.02K and leaving 4,395 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #864.
Geneos Wealth Management first reported a position in AOR in Q1 2016 and has held it in 42 quarters since. The position peaked at $742K in Q1 2021. 452 funds tracked by Wall St. Rank hold AOR as of Q2 2026.
- Geneos Wealth Management held 4,395 shares of iShares Core 60/40 Balanced Allocation ETF worth $305K as of Q2 2026.
- Geneos Wealth Management sold 15 iShares Core 60/40 Balanced Allocation ETF shares in Q2 2026, an estimated $1.02K.
- iShares Core 60/40 Balanced Allocation ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #864 holding.
- Geneos Wealth Management first reported a position in iShares Core 60/40 Balanced Allocation ETF in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's iShares Core 60/40 Balanced Allocation ETF position peaked at $742K in Q1 2021.
- 452 funds tracked by Wall St. Rank held iShares Core 60/40 Balanced Allocation ETF as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.